Matt Levine, Columnist

Silicon Valley Is On Drugs

Also private credit, the purpose of banking, bags of cash and biotech hedging.

June 27, 2023 at 6:03 PM UTC

Matt Levine is a Bloomberg Opinion columnist. A former investment banker at Goldman Sachs, he was a mergers and acquisitions lawyer at Wachtell, Lipton, Rosen & Katz; a clerk for the U.S. Court of Appeals for the 3rd Circuit; and an editor of Dealbreaker.

Provide news feedback or report an error

Site feedback:

Take our Survey

Uh, I don’t know, here’s one model for tech startups and venture capital:

I do not mean to endorse this model too much or anything, but here is a guy in the Wall Street Journal who believes it: